These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 25915139)
1. Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery. Jokisch V; Kroll R; Lutz B; Bindila L; Schaffelder R; Schaible T Am J Perinatol; 2015 Oct; 32(12):1145-50. PubMed ID: 25915139 [TBL] [Abstract][Full Text] [Related]
2. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes. Thompson Z; Argueta D; Garland T; DiPatrizio N Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680 [TBL] [Abstract][Full Text] [Related]
3. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856 [TBL] [Abstract][Full Text] [Related]
4. A column switching ultrahigh-performance liquid chromatography-tandem mass spectrometry method to determine anandamide and 2-arachidonoylglycerol in plasma samples. Marchioni C; de Souza ID; Grecco CF; Crippa JA; Tumas V; Queiroz MEC Anal Bioanal Chem; 2017 May; 409(14):3587-3596. PubMed ID: 28337517 [TBL] [Abstract][Full Text] [Related]
5. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans. Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319 [TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids concentrations in plasma associated with feed efficiency and carcass composition of beef steers. Artegoitia VM; Foote AP; Lewis RM; King DA; Shackelford SD; Wheeler TL; Freetly HC J Anim Sci; 2016 Dec; 94(12):5177-5181. PubMed ID: 28046144 [TBL] [Abstract][Full Text] [Related]
7. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245 [TBL] [Abstract][Full Text] [Related]
8. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study. Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763 [TBL] [Abstract][Full Text] [Related]
9. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity. Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262 [TBL] [Abstract][Full Text] [Related]
10. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953 [TBL] [Abstract][Full Text] [Related]
11. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305 [TBL] [Abstract][Full Text] [Related]
12. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder. Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878 [TBL] [Abstract][Full Text] [Related]
14. The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour. Nallendran V; Lam PM; Marczylo TH; Bankart MJ; Taylor AH; Taylor DJ; Konje JC BJOG; 2010 Jun; 117(7):863-9. PubMed ID: 20406230 [TBL] [Abstract][Full Text] [Related]
15. Circulating Endocannabinoids and Mortality in Hemodialysis Patients. Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741 [TBL] [Abstract][Full Text] [Related]
16. Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation. Patsenker E; Sachse P; Chicca A; Gachet MS; Schneider V; Mattsson J; Lanz C; Worni M; de Gottardi A; Semmo M; Hampe J; Schafmayer C; Brenneisen R; Gertsch J; Stickel F; Semmo N Int J Mol Sci; 2015 Mar; 16(4):7057-76. PubMed ID: 25826533 [TBL] [Abstract][Full Text] [Related]
17. A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery. van Ackern I; Kuhla A; Kuhla B Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684588 [TBL] [Abstract][Full Text] [Related]
18. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture. Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012 [TBL] [Abstract][Full Text] [Related]
19. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion. Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631 [TBL] [Abstract][Full Text] [Related]
20. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]